Tym00 0000 01
Tymlos Injection, Solution
Product Images NDC 70539-001
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Tymlos (NDC 70539-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Radius Health, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Tym00 0000 02
This is a description of a study on patient nonvertebral fracture incidence for alendronate monotherapy. The graph shows the incidence of fractures over a period of 25 months, with alendronate treatment starting at 19 months. The study compared the efficacy of alendronate to placebo and TYMLOS over a period of 25 months.*
Tym00 0000 03
This is a description of the TYMLOS pen, including the cartridge, cartridge holder, pen cap, injection button, dose knob, dose display window, and lot/exp information. There are two views of the pen provided: a front view and a rear view.*
Tym00 0000 04
This text is a list of items that are not included with the TYMLOS pen but are necessary parts of the pen needle, including the inner and outer pen needle caps, and the protective paper for the pen needle. The figure C likely refers to an accompanying diagram or illustration.*
Tym00 0000 05
Tym00 0000 06
Tym00 0000 07
Tym00 0000 08
Tym00 0000 09
Tym00 0000 10
Tym00 0000 11
Tym00 0000 12
Tym00 0000 13
Tym00 0000 14
Tym00 0000 15
Tym00 0000 16
Tym00 0000 17
Tym00 0000 18
Tym00 0000 19
Tym00 0000 20
Tym00 0000 21
Tym00 0000 22
TYMLOS' is a medication that is given through subcutaneous injection using a pre-filled pen. It contains 3120 mcg/1.56 mL (2000 mg/m) of ahaloparatide. The medication should be kept refrigerated until the first use, after which it can be stored at room temperature for up to 30 days. Unused portions should be discarded after 30 days. Before injecting, read the instructions for use carefully.*
Tym00 0000 23
Tym00 0000 24
TYMLOS' (abaloparatide) injection is a prescription drug for subcutaneous use and is meant for single patient use only. Each pre-filled pen contains enough doses for 30 injections. The medication needs to be kept refrigerated at 2°C - 8°C (36°F - 46°F) before the first use and after that, it can be stored for up to 30 days at a temperature range of 20°C - 25°C (68°F - 77°F). Unused portions should be discarded 30 days after opening. Before injecting, it is important to read the instructions for use. The drug is manufactured by Radius Health, Inc. in Boston, MA.*
Tym00 0000 25
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
